0 Comentários
0 Compartilhamentos
317 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Esoteric Testing Market Advancements in Molecular Testing and Infectious Disease DiagnosticsThe rapid evolution of healthcare diagnostics is transforming disease detection, treatment planning, and patient management. Advanced technologies in oncology diagnostic testing, immunology testing, and advanced diagnostic testing are enabling healthcare professionals to identify complex diseases with greater accuracy and speed. Specialized diagnostic approaches, including molecular assays,...0 Comentários 0 Compartilhamentos 362 Visualizações 0 Anterior
-
PCR Multiplex Assays Market Advances With Rising Demand for Rapid Multi-Target Molecular Testing" According to the latest report published by Data Bridge Market Research, the PCR Multiplex Assays Market CAGR Value As per Data Bridge Market Research Analysis the global PCR multiplex assays market size was valued at USD 632.60 Million in 2025 and is expected to reach USD 990.14 Million by 2033, at a CAGR of 5.76% during the forecast period The...0 Comentários 0 Compartilhamentos 257 Visualizações 0 Anterior
-
Polymerase Chain Reaction Market Expands With Rising Demand for Molecular Diagnostic Testing" According to the latest report published by Data Bridge Market Research, the Polymerase Chain Reaction Market CAGR Value As per Data Bridge Market Research Analysis the global polymerase chain reaction market size was valued at USD 10.88 billion in 2024 and is expected to reach USD 24.03 billion by 2032, at a CAGR of 10.4% during the...0 Comentários 0 Compartilhamentos 202 Visualizações 0 Anterior
-
Residual DNA Testing Market Forecast: Next-Generation Molecular Testing Technologies Shaping the IndustryThe NUT Midline Carcinoma Treatment Market is gaining attention as advancements in molecular diagnostics, targeted therapies, and precision oncology continue to transform the management of rare and aggressive cancers. NUT midline carcinoma (NMC) is an uncommon cancer caused primarily by genetic alterations involving the NUTM1 gene, leading to uncontrolled tumor growth. Due to its aggressive...0 Comentários 0 Compartilhamentos 378 Visualizações 0 Anterior
-
US Companion Diagnostics (CDx) Development Market Advancements in Molecular Diagnostics and Biomarker-Based TestingThe growing adoption of precision medicine has significantly changed the approach to cancer diagnosis and treatment. Advanced technologies such as oncology companion diagnostics, molecular diagnostics, and in vitro companion diagnostics are enabling healthcare providers to identify specific biomarkers, select targeted therapies, and improve patient outcomes. These diagnostic solutions are...0 Comentários 0 Compartilhamentos 311 Visualizações 0 Anterior
-
Molecular Methods Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Molecular Methods Market The global molecular methods market size was valued at USD 2.86 billion in 2025 and is expected to reach USD 4.90 billion by 2033, at a CAGR of 6.97% during the forecast period The market growth is largely fueled by the increasing adoption of advanced...0 Comentários 0 Compartilhamentos 529 Visualizações 0 Anterior
-
Personalized Medicine Driving the Pharmacogenomics Services MarketThe global pharmacogenomics services market was valued at USD 6.35 billion in 2025 and is projected to grow from USD 6.71 billion in 2026 to USD 10.41 billion by 2034, registering a CAGR of 5.65% during the forecast period (2026–2034). The market is witnessing significant growth due to the increasing adoption of precision medicine, rising...0 Comentários 0 Compartilhamentos 592 Visualizações 0 Anterior
-
Tuberculosis Testing Market AnalysisThe global TB diagnostics market was valued at USD 1.48 billion in 2025 and is projected to grow from USD 1.56 billion in 2026 to USD 2.41 billion by 2034, registering a CAGR of 5.56% during the forecast period (2026–2034). The market is expanding steadily due to the rising global burden of tuberculosis, increasing government initiatives...0 Comentários 0 Compartilhamentos 395 Visualizações 0 Anterior